These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 314343)
21. Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay. Gabizon A; Small M; Trainin N Int J Cancer; 1976 Dec; 18(6):813-9. PubMed ID: 992909 [TBL] [Abstract][Full Text] [Related]
22. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells. Röllinghoff M; Warner NL Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620 [No Abstract] [Full Text] [Related]
23. Lack of oral tolerance in C3H/HeJ mice. Kiyono H; McGhee JR; Wannemuehler MJ; Michalek SM J Exp Med; 1982 Feb; 155(2):605-10. PubMed ID: 7035600 [TBL] [Abstract][Full Text] [Related]
24. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma. Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630 [TBL] [Abstract][Full Text] [Related]
25. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro. Lynch DH; Gurish MF; Daynes RA Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587 [TBL] [Abstract][Full Text] [Related]
26. Two distinct populations of suppressor cells in the spleens of mice bearing methylcholanthrene-induced tumors. Pope BL; Whitney RB; Levy JG J Immunol; 1978 Jun; 120(6):2033-40. PubMed ID: 351063 [No Abstract] [Full Text] [Related]
27. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice. Gomi K; Morimoto M; Nomoto K Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572 [TBL] [Abstract][Full Text] [Related]
28. Failure of T cells specific for strong histocompatibility antigens to cooperate with B cells for a humoral response. Dennert G; De Rose M; Allen RS Eur J Immunol; 1977 Jul; 7(7):487-92. PubMed ID: 70364 [TBL] [Abstract][Full Text] [Related]
29. Nature of T-cells resident in spleens of thymectomized, lethally irradiated, bone marrow-reconstituted mice. Sado T; Kamisaku H; Aizawa S Cell Immunol; 1980 Jan; 49(1):51-63. PubMed ID: 6153157 [No Abstract] [Full Text] [Related]
30. Further studies on the effect of a transplanted methylcholanthrene-induced fibrosarcoma on humoral immunity in CBA mice. James K; Milne I; Warr G Clin Exp Immunol; 1974 Oct; 18(2):243-50. PubMed ID: 4468197 [TBL] [Abstract][Full Text] [Related]
31. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages. Elgert KD; Farrar WL J Immunol; 1978 Apr; 120(4):1345-53. PubMed ID: 305939 [TBL] [Abstract][Full Text] [Related]
32. Dept. of Microbiology, School of Medicine, East Carolina University, Greenville, NC. Gautam SC; Gautam S; Deodhar SD J Cancer Res Clin Oncol; 1981; 101(3):265-74. PubMed ID: 6458620 [TBL] [Abstract][Full Text] [Related]
33. Antibody production by spleen cells of mice bearing MCA-induced tumours: search for suppressor cells. Yagello M; Lespinats G; Fridman WH Int J Cancer; 1978 Aug; 22(2):136-41. PubMed ID: 359487 [TBL] [Abstract][Full Text] [Related]
34. Effect of cytomegalovirus infection on the growth of murine fibrosarcomas--evidence for two separate host defense mechanisms against tumors. Lannin DR; Howard RJ; Yu S; Collins AL; McKhann CF Surg Forum; 1979; 30():145-7. PubMed ID: 231846 [No Abstract] [Full Text] [Related]
35. [Splenocyte functional activity in mice growing the syngeneic transplantable hepatoma 22a]. Kiseleva EP; Malygin AM Tsitologiia; 1984 Dec; 26(12):1409-15. PubMed ID: 6335612 [TBL] [Abstract][Full Text] [Related]
36. Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts. Nelson DS; Hopper KE; Blanden RV; Gardner ID; Kearney R Cancer Lett; 1978 Aug; 5(2):61-7. PubMed ID: 308390 [TBL] [Abstract][Full Text] [Related]
37. Depletion of suppressor T cells in syngeneic chimeric mice. Rotter V; Trainin N Adv Exp Med Biol; 1976; 66():593-8. PubMed ID: 1083656 [TBL] [Abstract][Full Text] [Related]
38. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice. Bekesi JG; Roboz JP; Holland JF Isr J Med Sci; 1976; 12(4-5):288-303. PubMed ID: 181351 [TBL] [Abstract][Full Text] [Related]
39. Reversal of macrophage-augmented MLR reactivity by tumor-induced splenic suppressor T cells and their soluble factor(s). Connolly KM; Elgert KD Cell Immunol; 1979 Apr; 44(1):99-108. PubMed ID: 156587 [No Abstract] [Full Text] [Related]
40. Production of immunosuppressive factor(s) by a weakly immunogenic fibrosarcoma T 241. Gautam SC Anticancer Res; 1983; 3(4):263-8. PubMed ID: 6224458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]